Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lipid tucaresol as an adjuvant for methamphetamine vaccine development.

Literature DB >> 24615284

Lipid tucaresol as an adjuvant for methamphetamine vaccine development.

K C Collins¹, J E Schlosburg, J W Lockner, P T Bremer, B A Ellis, K D Janda.

Abstract

The immunopotentiator tucaresol was modified for incorporation into liposomes, where it was found to be a superior adjuvant to MPLA for vaccination against methamphetamine.

Entities: Chemical Gene Species

Mesh：

Substances：

Year: 2014 PMID： 24615284 PMCID： PMC4033696 DOI： 10.1039/c4cc00682h

Source DB: PubMed Journal: Chem Commun (Camb) ISSN： 1359-7345 Impact factor: 6.222

25 in total

1. Marked enhancement of the antigen-specific immune response by combining plasmid DNA-based immunization with a Schiff base-forming drug.

Authors: Jehad Charo; Maria Sundbäck; Ken Wasserman; Anne-Marie T Ciupitu; Babak Mirzai; Ruurd van der Zee; Rolf Kiessling
Journal: Infect Immun Date: 2002-12 Impact factor: 3.441

Review 2. Vaccine adjuvants: current state and future trends.

Authors: Nikolai Petrovsky; Julio César Aguilar
Journal: Immunol Cell Biol Date: 2004-10 Impact factor: 5.126

3. Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.

Authors: Gary R Matyas; Alexander V Mayorov; Kenner C Rice; Arthur E Jacobson; Kejun Cheng; Malliga R Iyer; Fuying Li; Zoltan Beck; Kim D Janda; Carl R Alving
Journal: Vaccine Date: 2013-04-23 Impact factor: 3.641

4. Liposomes as immunological adjuvants.

Authors: A G Allison; G Gregoriadis
Journal: Nature Date: 1974-11-15 Impact factor: 49.962

5. Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.

Authors: R L Richards; C R Alving; N M Wassef
Journal: J Pharm Sci Date: 1996-12 Impact factor: 3.534

Review 6. Mechanisms of neurotransmitter release by amphetamines: a review.

Authors: David Sulzer; Mark S Sonders; Nathan W Poulsen; Aurelio Galli
Journal: Prog Neurobiol Date: 2005-04 Impact factor: 11.685

Review 7. A prophylactic hepatitis B vaccine with a novel adjuvant system.

Authors: S Thoelen; N De Clercq; N Tornieporth
Journal: Vaccine Date: 2001-03-21 Impact factor: 3.641

8. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function.

Authors: S Soltysik; J Y Wu; J Recchia; D A Wheeler; M J Newman; R T Coughlin; C R Kensil
Journal: Vaccine Date: 1995 Impact factor: 3.641

9. Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs.

Authors: J Rhodes; H Chen; S R Hall; J E Beesley; D C Jenkins; P Collins; B Zheng
Journal: Nature Date: 1995-09-07 Impact factor: 49.962

10. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

Authors: Diane M Harper; Eduardo L Franco; Cosette Wheeler; Daron G Ferris; David Jenkins; Anne Schuind; Toufik Zahaf; Bruce Innis; Paulo Naud; Newton S De Carvalho; Cecilia M Roteli-Martins; Julio Teixeira; Mark M Blatter; Abner P Korn; Wim Quint; Gary Dubin
Journal: Lancet Date: 2004 Nov 13-19 Impact factor: 79.321

7 in total

Review 7. Vaccine-Induced CD8⁺ T Cell Responses in Children: A Review of Age-Specific Molecular Determinants Contributing to Antigen Cross-Presentation.

Authors: Elisabeth M S Beijnen; Simon D van Haren
Journal: Front Immunol Date: 2020-12-23 Impact factor: 7.561

7 in total

Lipid tucaresol as an adjuvant for methamphetamine vaccine development.

1. Marked enhancement of the antigen-specific immune response by combining plasmid DNA-based immunization with a Schiff base-forming drug.

Review 2. Vaccine adjuvants: current state and future trends.

3. Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.

4. Liposomes as immunological adjuvants.

5. Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.

Review 6. Mechanisms of neurotransmitter release by amphetamines: a review.

Review 7. A prophylactic hepatitis B vaccine with a novel adjuvant system.

8. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function.

9. Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs.

10. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

1. Methamphetamine Vaccines: Improvement through Hapten Design.

Review 2. Conjugate Vaccine Immunotherapy for Substance Use Disorder.

3. Heat shock proteins: A dual carrier-adjuvant for an anti-drug vaccine against heroin.

Review 4. Biologics to treat substance use disorders: Current status and new directions.

5. Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.

Review 6. Impact of methamphetamine on infection and immunity.

Review 7. Vaccine-Induced CD8⁺ T Cell Responses in Children: A Review of Age-Specific Molecular Determinants Contributing to Antigen Cross-Presentation.

Review 2. Vaccine adjuvants: current state and future trends.

Review 6. Mechanisms of neurotransmitter release by amphetamines: a review.

Review 7. A prophylactic hepatitis B vaccine with a novel adjuvant system.

Review 2. Conjugate Vaccine Immunotherapy for Substance Use Disorder.

Review 4. Biologics to treat substance use disorders: Current status and new directions.

Review 6. Impact of methamphetamine on infection and immunity.

Review 7. Vaccine-Induced CD8+ T Cell Responses in Children: A Review of Age-Specific Molecular Determinants Contributing to Antigen Cross-Presentation.

Review 7. Vaccine-Induced CD8⁺ T Cell Responses in Children: A Review of Age-Specific Molecular Determinants Contributing to Antigen Cross-Presentation.